KaloBios Pharmaceuticals (Nasdaq: KBIO) % HIGHER; seeing a big pop above its 50-day SMA, which is currently at 2.59 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Special Reports

Brean Capital Reiterates Buy on Keryx Biopharma (KERX) on Potential Catalysts and Improving Sales Dynamics September 4, 2015 9:02 AM UBS Cuts Price Target on Joy Global (JOY) to $20 as Company Takes Initiatives to Manage Downturn September 4, 2015 8:05 AM FBR Capital Remains Bullish on Methode Electronics (MEI) Following Announcements and EPS Beat September 4, 2015 7:21 AM